Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs

Bibliographic Details
Main Authors: Dengyuan Liu, Peng Wu, Wentao Gu, Cuihong Yang, Xinmeng Yang, Xingyu Deng, Jun Xu, Jingmei Jiang, Chengyu Jiang
Format: Article
Language:English
Published: Nature Publishing Group 2022-09-01
Series:Cell Discovery
Online Access:https://doi.org/10.1038/s41421-022-00454-7
_version_ 1811211577641140224
author Dengyuan Liu
Peng Wu
Wentao Gu
Cuihong Yang
Xinmeng Yang
Xingyu Deng
Jun Xu
Jingmei Jiang
Chengyu Jiang
author_facet Dengyuan Liu
Peng Wu
Wentao Gu
Cuihong Yang
Xinmeng Yang
Xingyu Deng
Jun Xu
Jingmei Jiang
Chengyu Jiang
author_sort Dengyuan Liu
collection DOAJ
first_indexed 2024-04-12T05:15:07Z
format Article
id doaj.art-aba62c447968412bad6aef9c209fd9ee
institution Directory Open Access Journal
issn 2056-5968
language English
last_indexed 2024-04-12T05:15:07Z
publishDate 2022-09-01
publisher Nature Publishing Group
record_format Article
series Cell Discovery
spelling doaj.art-aba62c447968412bad6aef9c209fd9ee2022-12-22T03:46:38ZengNature Publishing GroupCell Discovery2056-59682022-09-01811410.1038/s41421-022-00454-7Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugsDengyuan Liu0Peng Wu1Wentao Gu2Cuihong Yang3Xinmeng Yang4Xingyu Deng5Jun Xu6Jingmei Jiang7Chengyu Jiang8State Key Laboratory of Medical Molecular Biology, Department of Biochemistry, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical CollegeDepartment of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical CollegeDepartment of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical CollegeDepartment of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical CollegeState Key Laboratory of Medical Molecular Biology, Department of Biochemistry, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical CollegeState Key Laboratory of Medical Molecular Biology, Department of Biochemistry, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical CollegeEmergency Department, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical CollegeDepartment of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical CollegeState Key Laboratory of Medical Molecular Biology, Department of Biochemistry, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical Collegehttps://doi.org/10.1038/s41421-022-00454-7
spellingShingle Dengyuan Liu
Peng Wu
Wentao Gu
Cuihong Yang
Xinmeng Yang
Xingyu Deng
Jun Xu
Jingmei Jiang
Chengyu Jiang
Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs
Cell Discovery
title Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs
title_full Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs
title_fullStr Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs
title_full_unstemmed Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs
title_short Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs
title_sort potential of angiotensin ii receptor blocker telmisartan in reducing mortality among hospitalized patients with covid 19 compared with recommended drugs
url https://doi.org/10.1038/s41421-022-00454-7
work_keys_str_mv AT dengyuanliu potentialofangiotensiniireceptorblockertelmisartaninreducingmortalityamonghospitalizedpatientswithcovid19comparedwithrecommendeddrugs
AT pengwu potentialofangiotensiniireceptorblockertelmisartaninreducingmortalityamonghospitalizedpatientswithcovid19comparedwithrecommendeddrugs
AT wentaogu potentialofangiotensiniireceptorblockertelmisartaninreducingmortalityamonghospitalizedpatientswithcovid19comparedwithrecommendeddrugs
AT cuihongyang potentialofangiotensiniireceptorblockertelmisartaninreducingmortalityamonghospitalizedpatientswithcovid19comparedwithrecommendeddrugs
AT xinmengyang potentialofangiotensiniireceptorblockertelmisartaninreducingmortalityamonghospitalizedpatientswithcovid19comparedwithrecommendeddrugs
AT xingyudeng potentialofangiotensiniireceptorblockertelmisartaninreducingmortalityamonghospitalizedpatientswithcovid19comparedwithrecommendeddrugs
AT junxu potentialofangiotensiniireceptorblockertelmisartaninreducingmortalityamonghospitalizedpatientswithcovid19comparedwithrecommendeddrugs
AT jingmeijiang potentialofangiotensiniireceptorblockertelmisartaninreducingmortalityamonghospitalizedpatientswithcovid19comparedwithrecommendeddrugs
AT chengyujiang potentialofangiotensiniireceptorblockertelmisartaninreducingmortalityamonghospitalizedpatientswithcovid19comparedwithrecommendeddrugs